Direct Effect of Subthalamic Nucleus Stimulation on Levodopa-Induced Peak-Dose Dyskinesia in Patients with Parkinson’s Disease
- 1 September 2006
- journal article
- clinical trial
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 84 (4) , 176-179
- https://doi.org/10.1159/000094957
Abstract
We examined the direct effect of deep brain stimulation of the subthalamic nucleus (STN-DBS) on levodopa-induced peak-dose dyskinesia in 45 patients with Parkinson’s disease (PD) without reducing the levodopa dosage during the early period after surgery. In 8 patients (18%), the dyskinesia was quickly attenuated by bipolar stimulation in an experimental trial (5 min) with the contacts placed within the area above the STN. In contrast, bipolar stimulation using contacts placed within the STN itself tended to provoke or exacerbate the dyskinesia, indicating that dyskinesia could be inhibited by stimulation of the areas above the STN rather than the STN itself. In an attempt to control the cardinal symptoms of PD and dyskinesia at the same time, we employed bipolar stimulation with a longer interpolar distance as a therapeutic procedure (2 weeks), using contacts within the STN as a cathode and contacts within the area above the STN as an anode. Bilateral STN-DBS significantly attenuated the dyskinesia as evaluated by the dyskinesia severity rating scale (p < 0.05). In 24 patients (53%), almost complete control of the dyskinesia was observed. The contacts used as an anode in these patients were located more dorsally compared to those of the remaining patients, suggesting again that the dyskinesia was inhibited by stimulation of the areas above the STN rather than the STN itself. In the area above the STN, pallidothalamic, pallidosubthalamic and subthalamopallidal fibers are densely distributed. It appears that stimulation of these fibers may cause effects similar to thalamic or pallidal DBS and therefore inhibit peak-dose dyskinesia. Bipolar STN-DBS with contacts placed within the area above the STN as an anode appears to represent a useful option for controlling both the cardinal symptoms of PD and peak-dose dyskinesia at the same time.Keywords
This publication has 10 references indexed in Scilit:
- l -Dopa-induced dyskinesia improvement after STN-DBS depends upon medication reductionNeurology, 2004
- Immediate and sustained relief of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimulation leadNeurosurgical Focus, 2004
- Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contactsJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas—magnetic resonance imaging coregistration methodJournal of Neurosurgery, 2003
- Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imagingJournal of Neurosurgery, 2002
- Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patientsJournal of Neurosurgery, 2001
- Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complexJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's DiseaseNew England Journal of Medicine, 1998
- Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1993